| Product Code: ETC10939269 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Vaccine Contract Development and Manufacturing Organization Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, 2021 & 2031F |
3.3 China Vaccine Contract Development and Manufacturing Organization Market - Industry Life Cycle |
3.4 China Vaccine Contract Development and Manufacturing Organization Market - Porter's Five Forces |
3.5 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume Share, By Scale of Operation, 2021 & 2031F |
3.8 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume Share, By Client Type, 2021 & 2031F |
3.9 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume Share, By Technology Platform, 2021 & 2031F |
4 China Vaccine Contract Development and Manufacturing Organization Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for vaccines in China due to rising awareness about preventive healthcare |
4.2.2 Government initiatives to improve immunization coverage and vaccine availability |
4.2.3 Growth in research and development activities in the biopharmaceutical sector in China |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for vaccine manufacturing and testing |
4.3.2 High initial investment costs in establishing vaccine manufacturing facilities |
4.3.3 Intense competition among vaccine contract development and manufacturing organizations |
5 China Vaccine Contract Development and Manufacturing Organization Market Trends |
6 China Vaccine Contract Development and Manufacturing Organization Market, By Types |
6.1 China Vaccine Contract Development and Manufacturing Organization Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Service Type, 2021 - 2031F |
6.1.3 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Development Services, 2021 - 2031F |
6.1.4 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Manufacturing Services, 2021 - 2031F |
6.1.5 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By FillFinish Services, 2021 - 2031F |
6.2 China Vaccine Contract Development and Manufacturing Organization Market, By Vaccine Type |
6.2.1 Overview and Analysis |
6.2.2 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By mRNA Vaccines, 2021 - 2031F |
6.2.3 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Viral Vector Vaccines, 2021 - 2031F |
6.2.4 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Subunit Vaccines, 2021 - 2031F |
6.3 China Vaccine Contract Development and Manufacturing Organization Market, By Scale of Operation |
6.3.1 Overview and Analysis |
6.3.2 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Clinical Scale, 2021 - 2031F |
6.3.3 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Commercial Scale, 2021 - 2031F |
6.3.4 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Pilot Scale, 2021 - 2031F |
6.4 China Vaccine Contract Development and Manufacturing Organization Market, By Client Type |
6.4.1 Overview and Analysis |
6.4.2 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4.3 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.4.4 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Government Agencies, 2021 - 2031F |
6.5 China Vaccine Contract Development and Manufacturing Organization Market, By Technology Platform |
6.5.1 Overview and Analysis |
6.5.2 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By CellBased Platforms, 2021 - 2031F |
6.5.3 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Recombinant DNA Technology, 2021 - 2031F |
6.5.4 China Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By LiveAttenuated Platforms, 2021 - 2031F |
7 China Vaccine Contract Development and Manufacturing Organization Market Import-Export Trade Statistics |
7.1 China Vaccine Contract Development and Manufacturing Organization Market Export to Major Countries |
7.2 China Vaccine Contract Development and Manufacturing Organization Market Imports from Major Countries |
8 China Vaccine Contract Development and Manufacturing Organization Market Key Performance Indicators |
8.1 Percentage increase in research funding allocated to vaccine development in China |
8.2 Number of partnerships between vaccine manufacturers and research institutions in China |
8.3 Growth in the number of vaccine candidates in preclinical and clinical development stages in China. |
9 China Vaccine Contract Development and Manufacturing Organization Market - Opportunity Assessment |
9.1 China Vaccine Contract Development and Manufacturing Organization Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 China Vaccine Contract Development and Manufacturing Organization Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.3 China Vaccine Contract Development and Manufacturing Organization Market Opportunity Assessment, By Scale of Operation, 2021 & 2031F |
9.4 China Vaccine Contract Development and Manufacturing Organization Market Opportunity Assessment, By Client Type, 2021 & 2031F |
9.5 China Vaccine Contract Development and Manufacturing Organization Market Opportunity Assessment, By Technology Platform, 2021 & 2031F |
10 China Vaccine Contract Development and Manufacturing Organization Market - Competitive Landscape |
10.1 China Vaccine Contract Development and Manufacturing Organization Market Revenue Share, By Companies, 2024 |
10.2 China Vaccine Contract Development and Manufacturing Organization Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here